HomePMVP • NASDAQ
add
PMV Pharmaceuticals Inc
Previous close
$1.23
Day range
$1.22 - $1.40
Year range
$0.81 - $1.84
Market cap
65.18M USD
Avg Volume
1.72M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 22.88M | 13.43% |
Net income | -21.21M | -1,648.56% |
Net profit margin | — | — |
Earnings per share | -0.41 | -1,950.00% |
EBITDA | -22.85M | -15.40% |
Effective tax rate | -0.02% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 142.27M | -33.18% |
Total assets | 152.86M | -35.65% |
Total liabilities | 12.25M | -47.25% |
Total equity | 140.60M | — |
Shares outstanding | 52.99M | — |
Price to book | 0.46 | — |
Return on assets | -35.37% | — |
Return on capital | -37.77% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -21.21M | -1,648.56% |
Cash from operations | -18.30M | -1,045.31% |
Cash from investing | 10.99M | 372.92% |
Cash from financing | 103.00K | -26.95% |
Net change in cash | -7.21M | -927.29% |
Free cash flow | -10.70M | 9.03% |
About
Founded
2013
Website
Employees
47
